SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company...
Everest to receive total considerations of up to $455 million with $280 million in upfront payments...
Taiwan FDA accepts New Drug Application for Xerava for treatment of cIAI Everest enters into strate...
Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN...
Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN...
– Trodelvy is Everest's First Product to Receive Regulatory Approval in China – – Everest Plans to L...
FOSTER CITY, Calif. and SHANGHAI, June 4, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) ann...
SHANGHAI, May 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its li...
SHANGHAI, May 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its li...
China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for ...
SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa...
SHANGHAI, March 31, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical comp...
SHANGHAI, March 30, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its ...
SHANGHAI, March 29, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Compan...
SHANGHAI, March 15, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Compan...
SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines
SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its ...
SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Everest Medicines
2022-02-07 08:00
3754
SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- Everest Medicines
2022-01-14 08:00
4951
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines
2022-01-10 21:35
3716